These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 33112555)
1. The Clinical and Prognostic Implications of Pluripotent Stem Cell Markers Expression and Their Correlation with the WNT signal pathway in Hepatocellular Carcinoma. Osman NAA; Khalil AI; Yousef RK Asian Pac J Cancer Prev; 2020 Oct; 21(10):2961-2970. PubMed ID: 33112555 [TBL] [Abstract][Full Text] [Related]
2. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma. Kawai T; Yasuchika K; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Komori J; Hatano E; Kawaguchi Y; Uemoto S Sci Rep; 2016 Jul; 6():30489. PubMed ID: 27457505 [TBL] [Abstract][Full Text] [Related]
3. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway. Zhang W; Wu Y; Hou B; Wang Y; Deng D; Fu Z; Xu Z Mol Oncol; 2019 Oct; 13(10):2194-2210. PubMed ID: 31402556 [TBL] [Abstract][Full Text] [Related]
4. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling. Leung CO; Mak WN; Kai AK; Chan KS; Lee TK; Ng IO; Lo RC Oncotarget; 2016 May; 7(20):29371-86. PubMed ID: 27105493 [TBL] [Abstract][Full Text] [Related]
5. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374 [TBL] [Abstract][Full Text] [Related]
6. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546 [TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720 [TBL] [Abstract][Full Text] [Related]
8. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between EGFR and p53 in hepatocellular carcinoma. Cioca A; Cimpean A; Ceausu R; Fit AM; Zaharie T; Al-Hajjar N; Puia V; Raica M Asian Pac J Cancer Prev; 2014; 15(19):8069-73. PubMed ID: 25338986 [TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368 [TBL] [Abstract][Full Text] [Related]
12. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma. Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337 [TBL] [Abstract][Full Text] [Related]
13. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213 [TBL] [Abstract][Full Text] [Related]
14. P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. Qin LX; Tang ZY; Ma ZC; Wu ZQ; Zhou XD; Ye QH; Ji Y; Huang LW; Jia HL; Sun HC; Wang L World J Gastroenterol; 2002 Jun; 8(3):459-63. PubMed ID: 12046070 [TBL] [Abstract][Full Text] [Related]
15. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling. Qiao W; Wang H; Zhang X; Luo K Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355 [TBL] [Abstract][Full Text] [Related]
16. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma. Yuan RH; Jeng YM; Hu RH; Lai PL; Lee PH; Cheng CC; Hsu HC J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181 [TBL] [Abstract][Full Text] [Related]
17. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma. Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma Score and Subclassification Into Aggressive Subtypes Using Immunohistochemical Expression of p53, β-Catenin, CD133, and Ki-67. Abdou AG; Holah NS; Elazab DS; El-Gendy WG; Badr MT; Al-Sharaky DR Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):20-33. PubMed ID: 32287076 [TBL] [Abstract][Full Text] [Related]
19. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma. Zhang D; Ma X; Sun W; Cui P; Lu Z Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876 [TBL] [Abstract][Full Text] [Related]
20. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma. Ji J; Wei X; Wang Y Int J Clin Exp Pathol; 2014; 7(5):2470-6. PubMed ID: 24966958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]